Search for: "JOHNSON & JOHNSON CONSUMER INC." Results 41 - 60 of 865
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2012, 9:41 am
Last week Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson on Thursday announced a $181 million settlement with 36 states and the District of Columbia over charges of marketing anti-psychotic drugs for non-approved uses. [read post]
23 Mar 2007, 1:30 am
Congressman John Dingel has asked both Johnson & Johnson and Amgen Inc. to stop consumer advertising of their anemia medications for cancer patients until May 2007 or until the FDA wraps up an ongoing review. [read post]
18 May 2010, 7:03 pm by Carey, Danis & Lowe
The primary aim of the agreement is to protect consumers from gross misrepresentation of products such as the controversial antibiotic Levaquin, a specific Johnson & Johnson brand. [read post]
24 Sep 2010, 6:43 am
Johnson and Johnson's orthopedic division, DePuy Orthopedics, Inc., has issued a recall for two of their hip implant products, the ASR XL Acetabular System and the DePuy ASR Hip Resurfacing System. [read post]
17 Jan 2010, 10:20 am
Johnson&Johnson's McNeil Consumer Healthcare Products recalled batches of Tylenol Arthritis Caplets in November due to the smell, which caused nausea, stomach pain, vomiting and diarrhea. [read post]
11 Apr 2017, 1:20 pm by Phyllis H. Marcus and Emma Lewis
Johnson & Johnson to Discontinue Certain Sunscreen Claims after NAD Proceedings The NAD recommended that Johnson & Johnson Consumer, Inc., modify or discontinue certain claims made for its Neutrogena UltraSheer Dry-Touch Sunscreen SPF 100+ after a competitor challenge by Bayer Healthcare LLC. [read post]
23 Aug 2011, 12:23 pm by info@thomasjhenrylaw.com
In a controversial move, Johnson & Johnson's DePuy Orthopaedics Inc. unit has hired a third party (Broadspire Services Inc.) to handle patient claims associated with the recall of their metal ASR hip systems. [read post]
16 Jan 2014, 6:20 am
Mead Johnson had argued that the survey evidence offered by PBM should be excluded as the consumers involved in the survey did not exactly match the "universe" of consumers appropriate to this litigation. [read post]
31 May 2010, 6:51 am by Rosenbaum & Associates
While drug companies are required to notify the FDA of consumer complaints within three days, Johnson & Johnson waited nearly a year to do so. [read post]
14 Nov 2013, 5:00 am
It was recently announced that the state of Vermont will receive almost $1.4M in the consumer fraud lawsuit against Johnson & Johnson and Janssen Pharmaceuticals. [read post]
17 Apr 2014, 6:12 pm by CSSFIRM.COM
Janssen Pharmaceutical Inc. agreed to the settlement without admitting to any wrongdoing, as part of a deal that prevents it from misleading consumers about its drugs in the future. [read post]
28 Jul 2023, 7:41 am by Dan Bressler
” “Tilray Inc. and its subsidiary High Park Holdings Ltd. accused Patrick Moen on Thursday of violating ethics rules by aiding Docklight Brands Inc. [read post]
14 Oct 2011, 3:35 am by John L. Welch
" In short, Johnson's evidence of acquired distinctiveness fell short of showing "that consumers have been conditioned to perceive the particular combinations of design features claimed in each application as source-indicating trademarks. [read post]
  NAD Cleans Up Persil Advertising Claims On May 25, 2017, Henkel Consumer Goods, Inc. [read post]
29 Jun 2012, 6:33 am by William A. Ruskin
The Texas Supreme Court rendered judgment in favor of Centocor, Inc., the pharmaceutical manufacturer subsidiary of Johnson & Johnson, in a landmark decision involving the learned intermediary doctrine, Centocor, Inc. v. [read post]
10 Aug 2006, 2:59 pm
The Food and Drug Administration recently rejected approval of Cephalon Inc.'s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
A South Carolina judge has ordered a Johnson & Johnson subsidiary to pay $327 million in fines for deceptive marketing of their anti-psychotic drug, Risperdal. [read post]
15 Sep 2011, 5:31 pm by Rebecca Tushnet
General Mills, Inc. --- F.R.D. ----, 2011 WL 4056208 (C.D. [read post]